期刊文献+

大鼠慢性心力衰竭急性应激模型的建立及评价 被引量:4

Establishment and evaluation of rat model of acute stress during chronic heart failure
下载PDF
导出
摘要 目的建立慢性心力衰竭急性应激状态的大鼠模型并进行评价。方法Wistar大鼠反复腹腔注射阿霉素导致慢性心力衰竭,6周时行血流动力学和病理学评价。慢性心衰大鼠给予细菌脂多糖腹腔注射导致急性应激状态,测定血压、心率及血红素氧合酶-1(HO-1)的表达。结果阿霉素腹腔注射成功制备出慢性心力衰竭大鼠模型。与正常组相比,模型组大鼠心脏出现心肌纤维化和心肌细胞肥大,左心室收缩与舒张的最大速率(±LVdp/dtmax)明显下降。细菌脂多糖腹腔注射成功导致心衰大鼠发生急性应激,注射后0.5h心率加快,血压开始上升,1h达高峰;注射后6hHO-1表达升高,12h升高更为显著,心衰大鼠较正常组大鼠升高更显著。结论细菌脂多糖腹腔注射可成功导致阿霉素心衰大鼠产生急性应激状态,为慢性心衰急性发作的病理状态的研究提供了可靠的动物模型。 Objective To establish the rat model of acute stress during chronic heart failure and evaluate it. Methods Male Wistar rats were injected adrimycin (ADR) via abdominal cavity to induce heart failure. Cardiovascular dynamics and heart pathology were measured. Rats with heart failure received bacterial lipopolysaccharide (LPS) 0.2 mg/kg by peritoneal injection to induce acute stress, and we measured blood pressure, heart rate and the expression of HO-1 after LPS injection. Results ADR peritoneal injection led to heart failure successfully. Compared with that in normal group, left ventricular function (± LVdp/dtmax) of rats in model group reduced significantly, and myocardial fibrosis and hypertrophy occurred, too. LPS peritoneal injection led to acute stress in rats with heart failure. Heart rate and blood pressure began to rise 0.5 h after LPS injection and reached at 1 h after LPS injection. The expression of myocardium HO-1 increased at 6 h and was significantly higher at 12 h after LPS injection. The expression of HO-1 was higher in model group than in normal group. Conclusion LPS peritoneal injection successfully leads to acute stress in rats with heart failure, providing a reliable model for study of decompensated heart failure.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第1期33-35,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 慢性心力衰竭 应激 血红素氧合酶 大鼠 chronic heart failure stress heme oxygenase rat
  • 相关文献

参考文献7

  • 1MANN DL, BRISTOW MR. Mechanisms and models in heart failure: the biomechanical model and beyond [J]. Circulation, 2005, 111(21) :2837-2849.
  • 2方显明,韦斌,郎中云,黄孟军.安心颗粒对阿霉素性心衰大鼠心肌细胞凋亡的影响[J].第四军医大学学报,2007,28(14):1326-1328. 被引量:5
  • 3ISHIDA M, TOMITA S, NAKATANI T, et al. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-indueed cardiomyopathy [J]. J Heart Lung Transplant, 2004, 23(4) :436-445.
  • 4MATSUSHITA A, IWASE M, KATO Y, et al. Differential cardiovascular effects of endotoxin derived from Escherichia coli or Pseudomonas aeruginosa [J]. Exp Anim, 2007, 56(5):339-348.
  • 5TISSIER S, LANCEL S, MARECHAL X, et al. Calpain inhibitors improve myocardial dysfunction and inflammation induced by endotoxin in rats [J]. Shock, 2004, 21(4):352-357.
  • 6VONA-DAVIS L, WEARDEN PD, KARNE NH, et al. Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia [J]. J Surg Res, 2002, 103(1):1-7.
  • 7MENG X, BROWN JM, AO L, et al. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats [J]. Am J Physiol, 1996, 271(4):1316-1324.

二级参考文献5

  • 1王强,何劲松,方显明,杨小英,莫雪梅.加用安心颗粒治疗冠心病无症状性心力衰竭临床观察[J].广西中医学院学报,2005,8(3):20-21. 被引量:12
  • 2Kang PM,Izumo S.Apoptosis and heart failure:A critical review of the literature[J].Circ Res,2000,86(11):1107-1113.
  • 3Kalyanaraman B,Joseph J,Kalivendi S,et al.Doxorubicin-induced apoptosis:Implications in cardiotoxicity[J].Mol Cell Biochem,2002,234-235(1-2):119-124.
  • 4Haunstetter A,Izumo S.Future perspectives and potential implications of cardiac myocyte apoptosis[J].Cardiovasc Res,2000,45(3):795-801.
  • 5Narula J,Kolodgie FD,Virmani R.Apoptosis and cardomyopathy[J].Curr Opin Cardiol,2000,15 (3):183-188.

共引文献4

同被引文献47

  • 1睢大员,于晓风,曲绍春林大学药学院药理教研室,徐华丽,王绍.西洋参叶20s-原人参二醇组皂苷对大鼠实验性心室重构的影响[J].中国药学杂志,2007,42(2):108-112. 被引量:36
  • 2Goldstein S, Ali AS, Sabbah H, et al. Ventricular remodeling: Mechanisms and prevention[J]. Cardiol Clin, 1998, 16 (4): 623-632.
  • 3Solomon SD, Pfeffe MA. Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: wherewe stand today[J]. Am Heart J, 1998, 136 (6): 931-933.
  • 4Wang T, Yu XF, Qu SC, et al. Effect of ginsenoside b3 on myocardial injury and heart function impairment induced by isoproterenol in rats [J]. Eur J Pharmaeol, 2010,636 (1-3): 121-125.
  • 5Wang T, Yu XF, Qu SC, et al. Gensenoside Rba inhibits angiotensin II-induced vascular smooth muscle cell proliferation [J]. Basic Clin Pharmacol Toxicol, 2010, 107 (2): 685-689.
  • 6PfefferMA, Braunwald E. Ventricular remodeling after myocaradial infarction. Experimental observations and clinical implications [J].Circulation, 1990, 81 (4): 1161-1172.
  • 7Deedwania PC. Prevention of heart failure and postinfarction remodeling [J]. Cardiol Clin, 1994, 12 (1): 155-164.
  • 8Oliverri R. Left ventricular remodeling after myocardial infarction : pathophysiology and therapy[J]. Clin Cardioi New Front, 2000, 101 (25) : 2981-2988.
  • 9Shen XC, Qiau ZY. Effects of crocetin of antioxidant enzymatic activities in cardiac hypertrophy induced by norepinephrinein rats [J]. Pharmazie, 2006, 61 (4):348- 352.
  • 10Pattern RD, Aronovitz MJ, Einstein M, et al. Effects of angiotensin Ⅱ receptor blockade versus angiotensin-convertingenzyme inhibition on ventricular remodelling following myocardial infarction in the mouse[J].Clin Sci (Lond), 2003, 104 (2), 109-118.

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部